Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Fukuda

Showing results (151-160 of 254) with videos related to

Pageof 26
Sort By:
Cancer Chemotherapy and Pharmacology|March 8, 2006
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancerSeiji Nagashima, Hiroshi Soda, Mikio Oka, et al.
Thoracic Cancer|September 26, 2018
Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanomaTakaya Ikeda, Hiroyuki Yamaguchi, Yosuke Dotsu, et al.
Anticancer Research|June 3, 2006
Both bronchial and vascular stenting followed by chemoradiotherapy for locally advanced non-small cell lung cancerMinoru Fukuda, Yasushi Obase, Naoyuki Miyashita, et al.
Journal of Medical Microbiology|October 13, 2006
Mutation of luxS affects motility and infectivity of Helicobacter pylori in gastric mucosa of a Mongolian gerbil modelTakako Osaki, Tomoko Hanawa, Taki Manzoku, et al.
Japanese Journal of Clinical Oncology|June 30, 2007
Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non-small cell lung cancerHiroshi Takatani, Hiroshi Soda, Yoichi Nakamura, et al.
Anticancer Research|June 29, 2007
Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinomaMinoru Fukuda, Yasushi Obase, Naoyuki Miyashita, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2008
Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone)Hiroyuki Yamaguchi, Shigeru Kamiya, Tomonori Uruma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2014
Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sitesMotohiro Nonaka, Xingfeng Bao, Fumiko Matsumura, et al.
Thoracic Cancer|November 14, 2017
Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumabKazuaki Okamura, Yuichi Fukuda, Hiroshi Soda, et al.
International Journal of Cancer|November 6, 2003
Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cellsYasuo Inaba, Chikara Ohyama, Tetsuro Kato, et al.
Pageof 26

Showing results (151-160 of 254) with videos related to

Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|March 8, 2006
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancerSeiji Nagashima, Hiroshi Soda, Mikio Oka, et al.
Thoracic Cancer|September 26, 2018
Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanomaTakaya Ikeda, Hiroyuki Yamaguchi, Yosuke Dotsu, et al.
Anticancer Research|June 3, 2006
Both bronchial and vascular stenting followed by chemoradiotherapy for locally advanced non-small cell lung cancerMinoru Fukuda, Yasushi Obase, Naoyuki Miyashita, et al.
Journal of Medical Microbiology|October 13, 2006
Mutation of luxS affects motility and infectivity of Helicobacter pylori in gastric mucosa of a Mongolian gerbil modelTakako Osaki, Tomoko Hanawa, Taki Manzoku, et al.
Japanese Journal of Clinical Oncology|June 30, 2007
Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non-small cell lung cancerHiroshi Takatani, Hiroshi Soda, Yoichi Nakamura, et al.
Anticancer Research|June 29, 2007
Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinomaMinoru Fukuda, Yasushi Obase, Naoyuki Miyashita, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2008
Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone)Hiroyuki Yamaguchi, Shigeru Kamiya, Tomonori Uruma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2014
Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sitesMotohiro Nonaka, Xingfeng Bao, Fumiko Matsumura, et al.
Thoracic Cancer|November 14, 2017
Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumabKazuaki Okamura, Yuichi Fukuda, Hiroshi Soda, et al.
International Journal of Cancer|November 6, 2003
Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cellsYasuo Inaba, Chikara Ohyama, Tetsuro Kato, et al.
Pageof 26